Certara, Inc. filings document the public-company record for a Nasdaq-listed provider of biosimulation software and model-informed drug development services. Its 8-K reports include operating and financial results, guidance-related exhibits, material-event disclosures, credit agreement amendments and the completed sale of its global medical writing and related regulatory services business.
Proxy and governance filings describe annual-meeting matters, board composition, executive transitions and stockholder voting procedures. The record also identifies Certara's common stock, capital-structure disclosures and clinical or regulatory disclosures tied to software, services, regulatory science and clinical-development support.
Certara, Inc. reported the final voting results from its annual meeting of stockholders held on May 14, 2026. Three director nominees received large majorities of votes cast, with Arjun Bedi receiving 121,707,485 votes for and 1,028,187 withheld, Stephen McLean receiving 99,884,645 for and 22,851,027 withheld, and Jon Resnick receiving 121,713,279 for and 1,022,393 withheld. Separate proposals also drew strong support, including one with 141,730,429 votes for, 764,353 against and 122,547 abstentions, and another with 120,333,107 votes for, 2,289,297 against and 113,268 abstentions, alongside broker non-votes.
Certara, Inc. director Cynthia Collins acquired 15,757 shares of common stock through the vesting of restricted stock units. On May 14, 2026, 15,757 RSUs granted on May 21, 2025 under the Certara, Inc. 2020 Incentive Plan converted into an equal number of common shares. Following this routine equity compensation event, Collins directly holds 51,846 shares of Certara common stock.
Certara, Inc. director and Chief Financial Officer John V. W. Reynders reported equity compensation activity involving restricted stock units. On May 14, 2026, 15,757 RSUs granted under the 2020 Incentive Plan vested and were converted into 15,757 shares of common stock, increasing his direct common stock holdings to 26,466 shares. On the same date, he received a new grant of 33,222 RSUs, each representing a right to receive one share of common stock, which will vest on the earlier of the one-year anniversary of grant or the issuer's next annual meeting. The filing shows only awards and exercises of equity compensation, with no open-market purchases or sales.
Certara, Inc. board chairman Eran Broshy reported equity compensation activity involving restricted stock units tied to the company’s common stock. On May 14, 2026, 15,757 RSUs granted on May 21, 2025 vested and were converted into 15,757 shares of common stock, increasing his direct holdings to 50,708 shares.
On the same date, he received a new grant of 33,222 RSUs under the 2020 Incentive Plan, each convertible into one share of common stock. These RSUs vest on the earlier of the one-year anniversary of grant or Certara’s next annual meeting, providing additional stock-based compensation but involving no open-market purchases or sales.
Certara, Inc. director Arjun Bedi reported equity compensation activity involving restricted stock units and common shares. On May 14, 2026, 5,547 previously granted RSUs vested and were converted into 5,547 shares of common stock, which he now holds directly.
Also on that date, Bedi received a new grant of 33,222 RSUs under the Certara, Inc. 2020 Incentive Plan. Each RSU entitles him to one share of common stock, vesting on the earlier of the one-year anniversary of the grant or the company’s next annual meeting.
Certara, Inc. director and chairman James E. Cashman III reported routine equity compensation activity. He exercised 15,757 restricted stock units (RSUs) into common stock on May 14, 2026, tied to awards granted under the 2020 Incentive Plan and scheduled to vest at the issuer's annual meeting.
On the same date, he received a new grant of 33,222 RSUs under the same plan, each representing a right to one share of common stock that will vest on the earlier of one year from grant or the next annual meeting. Following these transactions, he directly holds 484,197 shares of common stock and 33,222 RSUs, with no open‑market purchases or sales disclosed in this filing.
Certara director Nancy Killefer increased her equity position through routine equity compensation events. On May 14, 2026, 15,757 restricted stock units granted on May 21, 2025 vested and were converted into 15,757 shares of common stock. On the same date, she received a new grant of 33,222 restricted stock units under Certara’s 2020 Incentive Plan, each representing one future share of common stock. Following these transactions, she directly holds 51,846 shares of common stock and 33,222 restricted stock units.
Certara, Inc. director Rosemary A. Crane exercised restricted stock units into common shares as part of her equity compensation. On May 14, 2026, 15,757 restricted stock units granted under the Certara, Inc. 2020 Incentive Plan vested and were converted into 15,757 shares of common stock. Following the transaction, she directly owned 45,672 shares of Certara common stock. No open-market purchases or sales were reported in this filing.
Certara director Matthew M. Walsh reported equity compensation activity involving restricted stock units (RSUs) and common stock. On May 14, 2026, 15,757 RSUs vested and were converted into 15,757 shares of Certara common stock under the 2020 Incentive Plan, increasing his direct common stock holdings to 213,316 shares.
On the same date, he also received a new grant of 33,222 RSUs under the 2020 Incentive Plan, each RSU representing a right to receive one share of common stock. These new RSUs vest on the earlier of the one-year anniversary of the grant date or the date of Certara’s next annual meeting.
Certara, Inc. reported that executive Robert Aspbury, President of Predictive Tech, received new equity awards on May 11, 2026. He was granted 129,629 Performance Stock Units (PSUs) and two Restricted Stock Unit (RSU) awards covering 246,913 and 86,419 underlying shares of common stock.
Footnotes explain that PSUs can pay out between 0% and 200% of the target amounts based on Certara’s total shareholder return through periods ending March 31, 2028 and March 31, 2029. The RSUs vest in three equal installments on April 1, 2027, April 1, 2028, and April 1, 2029. A separate block of 68,348 PSUs was granted and then fully canceled in an issuer disposition, reflecting an amendment of earlier awards.